Ralf Reilmann
Affiliations: | Neurology | University of Munster, Münster, Nordrhein-Westfalen, Germany |
Area:
Huntington's diseaseGoogle:
"Ralf Reilmann"Mean distance: 17.1 (cluster 22) | S | N | B | C | P |
Parents
Sign in to add mentor| Andrew M. Gordon | post-doc | 1996-2000 | Teachers College, Columbia University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Oosterloo M, Touze A, Byrne LM, et al. (2024) Clinical Review of Juvenile Huntington's Disease. Journal of Huntington's Disease |
| Reilmann R, Anderson KE, Feigin A, et al. (2024) Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study. The Lancet. Neurology |
| Saft C, Burgunder JM, Dose M, et al. (2023) Symptomatic treatment options for Huntington's disease (guidelines of the German Neurological Society). Neurological Research and Practice. 5: 61 |
| Lunven M, Hernandez Dominguez K, Youssov K, et al. (2023) A new approach to digitized cognitive monitoring: validity of the SelfCog in Huntington's disease. Brain Communications. 5: fcad043 |
| Hare E, Bachoud-Lévi AC, Reilmann R, et al. (2022) Cognitive processes of apathy in Huntington's disease show high sensitivity to disease progression. Clinical Parkinsonism & Related Disorders. 7: 100168 |
| Gaßner H, Jensen D, Marxreiter F, et al. (2020) Correction to: Gait variability as digital biomarker of disease severity in Huntington's disease. Journal of Neurology |
| Gaßner H, Jensen D, Marxreiter F, et al. (2020) Gait variability as digital biomarker of disease severity in Huntington's disease. Journal of Neurology |
| Reilmann R. (2019) Parkinsonism in Huntington's disease. International Review of Neurobiology. 149: 299-306 |
| Schaeffer E, Streich S, Wurster I, et al. (2019) How to evaluate effects of occupational therapy - lessons learned from an exploratory randomized controlled trial. Parkinsonism & Related Disorders. 67: 42-47 |
| Ross CA, Reilmann R, Cardoso F, et al. (2019) Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories. Movement Disorders Clinical Practice. 6: 541-546 |